loadpatents
name:-0.0014338493347168
name:-0.0018010139465332
name:-0.0012118816375732
Hwang; Hey-Min Patent Filings

Hwang; Hey-Min

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hwang; Hey-Min.The latest application filed is for "isoxazole derivatives as nuclear receptor agonists and uses thereof".

Company Profile
1.1.2
  • Hwang; Hey-Min - Seoul KR
  • HWANG; Hey-Min - Jung-gu Seoul
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Isoxazole Derivatives As Nuclear Receptor Agonists And Uses Thereof
App 20210188790 - KANG; Jae-Hoon ;   et al.
2021-06-24
Isoxazole derivatives as nuclear receptor agonists and uses thereof
Grant 10,988,449 - Kang , et al. April 27, 2
2021-04-27
Isoxazole Derivatives As Nuclear Receptor Agonists And Uses Thereof
App 20200115349 - KANG; Jae-Hoon ;   et al.
2020-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed